GlucagonLike Peptide1 Targets in the Human Nodose Ganglion. Journal of Comparative Neurology , vol
Therefore, we believe that the discovery of low-cost oral GLP-1RA analogues or synergists and the continuous elucidation of the possible mechanism of action of GLP-1 are of great significance for the expansion of the field of disease treatment
Primary Research: Synergistic lipolysis, triple-agonist kinetics, & rapid weight-related signaling shifts
British Journal of Pharmacology , 179(4), 557570
Orforglipron is a once-a-day pill that acts on glucagonlike peptide 1 (GLP-1) receptors
Long-term studies also show that patients can maintain their weight loss with continued use of GLP-1 medications, especially when combined with healthy lifestyle changes